Complex coronary cases
High Risk PCI of Multiple Calcific Lesions of RCA – Feb 2014

Case: 82-year-old male with exertional dyspnea and negative stress MPI underwent coronary CTA revealing extensive calcific three vessel coronary artery disease. A cardiac cath on January 10, 2014 revealed calcific three vessel CAD with high SYNTAX score of 36. Heart Team consultation recommended CABG but was declined by the patient due to prior small CVA. Patient continued to be symptomatic despite optimal medical therapy. Now planned for high- risk PCI of multiple calcific lesions of RCA as the first part of multivessel staged PCI.
Moderator: Sameer Mehta, MD

1:04:41

Q&A
Q
In which lesion will you not use Orbital Atherectomy (OA)?
A.

Both Rotational and Orbital atherectomy are appropriate for most of the heavily calcified lesions, with a caveat that OA should not be used in the aorto-ostial lesions, post failed PTCA, large vessels and angulated lesions (>90degree).


Q
How does the cost of Orbital Atherectomy compare with Rotablator?
A.

Overall list price of OA is around $3750 and of Rotablator it is around $1500.


Q
In which sub groups of patient do you think Orbital Atherectomy offers advantage over Rotablator? Or it is mainly the ease of use?
A.

Besides the ease of use, OA will be helpful in pts with borderline hemodynamics (low BP, CHF) as it causes less slow flow and is tolerated better with the pts. Also very distal coronary lesions could be preferentially treated by OA.


Q
What device would Orbital Atherectomy impact - Cutting Balloon, Rotablator or AngioSculpt?
A.

OA will compete directly with Rotablator in heavily calcifies lesions. Cutting balloon and AngioSculpt may still be adjunct to OA in large vessels before stenting.


Q
Are some specific registries recommended for highlighting specific indications of Orbital Atherectomy?
A.

Besides ORBIT II trial data, there has been limited publications of OA so far. Certainly a well maintained registry for prospective use of OA and as well as Rotablator will be very useful in defining their comparative use and occurrence of various complications. Ongoing MACE trial will answer the question of impact of various degree of calcium in the coronary lesions, in terms of 30 day MACE outcomes after Rotablator and other plaque modifying technologies but not OA.


Q
What shortcomings about Rotational Atherectomy are contributing to exploration of alternative strategies?
A.

Thin Rota guide wire (0.009” is the Achilles heel of Rotablator) along with its complex setup, need for Nitrogen tank and occurrence of procedural complication of slow flow, are the important short comings which has limited Rotablator use to <2% of PCI (while heavily calcified lesions are noted in about 8-10% of cases).


Q
How would no reflow rates compare between Rotational atherectomy (RA) and Orbital atherectomy?
A.

Incidence of no reflow and slow flow seems to be lower with OA vs. Rotablator, but will need large number of pts to make a meaningful and convincing observation. The main reason behind this differential incidence is likely due to the fact that OA burr due to vertical motion, is rarely obstructing the lesion and hence sanding the calcified plaque slowly.


Q
Is there a need for a pharmacological cocktail therapy for Orbital Atherectomy?
A.

YES it is part of the flush solution and concentration of heparin, nitro and verapamil is half of what we use for Rotablator. Typically we use 2.5mg nitro, 2500U heparin and 2.5mg verapamil in 1L NS bag. We also use Viper glide in the flush bag just like Rota glide for Rotablator.


Q
Since beginning Orbital Atherectomy, how has your distribution of atherectomy devices changed?
A.

At present both OA and RA use is equal (about 50%) in our lab; of the total 40 of the 400 PCI cases each month, OA is being used in 18-20 cases per month.


Q
Is the need for pacing for Orbital Atherectomy same as for Rotablation?
A.

At present temporary pacing is used in dominant RCA, dominant LCx and unprotected LM lesions, with both RA and OA procedures. Our personal experience has been that actual requirement of pacemaker is very rare during OA case vs RA case. Hence with further experience, we might recommend only selective use of pacemaker with OA procedures.


comments

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Mount Sinai Hospital, One Gustave L. Levy Place, Box, New York, NY, 10029, https://ccclivecases.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

suggestion
Suggestions
Staged PCI of RCA multilayer DES CTO ISR using rotational atherectomy and IVBT – November 2020
Views 370

Case and Plan: 65-year old male with known long standing history of chronic ischemic heart disease requiring multiple PCI’s over the years after declining CABG, presented with CCS Class III angina and high risk stress MPI for multivessel ischemia. A Cardiac Cath on September 28, 2020 revealed 3 V CAD: 100% proximal RCA due to […]


Complex prox RCA CTO Recanalization via Retrograde Approach – February 2021
Views 142

56-year-old male presented with Class III unstable angina and positive stress MPI for significant inferior ischemia. A Cardiac Cath on November 20, 2020 at outside hospital revealed 2 V VAD: 85% mid LAD, 70% D1 and CTO proximal RCA with distal vessel fills retrogradely via septal collaterals (J-CTO Score 3), LVEF = 50% and Syntax […]


High-Risk Complex PCI of Diffuse Multivessel CAD – January 2021
Views 453

  Case and Plan: 45-year-old male with multiple CAD risk factors presented to OSH on November 6, 2020 with unstable angina and positive ETT. A Cardiac Cath on November 9, 2020 revealed extensive 3V CAD: 100% mid LAD, 90% D2, 70% proximal LCx, 100% LCx-OM1, 100% mid RCA with LVEF = 60% and SYNTAX Score […]


Extremely Tortuous Angulated mid LAD Diagonal Bifurcation Lesion – December 2020
Views 620

Case and Plan: 75-year-old female presented with new onset CCS Class II angina and positive stress MPI on November 9, 2020 revealing moderate apical and inferior ischemia. A Cardiac Cath on November 24, 2020 revealed 2 V CAD: 95% proximal RCA, angulated tortuous 95% mid LAD bifurcation lesion, LVEF = 60% and SYNTAX Score = […]